Skip to main content
TipRanks
Go Ultimate75% OFF

Pyxis Oncology (PYXS) Ratios

704 Followers

Pyxis Oncology Ratios

PYXS's free cash flow for Q3 2026 was $-16.29M. For the 2026 fiscal year, PYXS's free cash flow was increased by $0.00 and operating cash flow was $-16.29M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio3.417.494.845.9014.90
Quick Ratio3.417.494.845.9014.90
Cash Ratio0.731.100.385.6714.69
Solvency Ratio-1.97-2.04-1.50-2.37-4.03
Operating Cash Flow Ratio-3.01-3.26-2.75-2.82-1.89
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 33.99M$ 96.01M$ 76.58M$ 136.06M$ 259.96M
Leverage Ratios
Debt-to-Assets Ratio0.200.130.120.090.00
Debt-to-Equity Ratio0.350.170.170.120.00
Debt-to-Capital Ratio0.260.140.150.110.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.711.301.381.311.07
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.300.350.530.570.01
Net Debt to EBITDA-0.04-0.01-0.151.313.98
Profitability Margins
Gross Profit Margin82.77%97.06%0.00%0.00%0.00%
EBIT Margin-564.55%-424.23%0.00%0.00%0.00%
EBITDA Margin-532.00%-405.76%0.00%0.00%0.00%
Operating Profit Margin-609.18%-554.07%0.00%0.00%0.00%
Pretax Profit Margin-564.55%-492.35%0.00%0.00%0.00%
Net Profit Margin-574.55%-478.95%0.00%0.00%0.00%
Continuous Operations Profit Margin-574.55%-478.95%0.00%0.00%0.00%
Net Income Per EBT101.77%97.28%100.00%100.00%100.00%
EBT Per EBIT92.67%88.86%89.77%97.76%108.98%
Return on Assets (ROA)-87.00%-49.20%-42.47%-57.11%-27.13%
Return on Equity (ROE)-149.08%-64.04%-58.70%-75.06%-29.07%
Return on Capital Employed (ROCE)-119.93%-64.13%-55.55%-68.70%-26.68%
Return on Invested Capital (ROIC)-117.12%-61.74%-55.09%-68.70%-26.66%
Return on Tangible Assets-87.00%-50.03%-49.38%-57.11%-27.13%
Earnings Yield-111.41%-84.82%-102.73%-272.72%-21.49%
Efficiency Ratios
Receivables Turnover19.800.000.000.000.00
Payables Turnover0.220.100.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.710.730.000.000.00
Asset Turnover0.150.100.000.000.00
Working Capital Turnover Ratio0.170.150.000.000.00
Cash Conversion Cycle-1645.31-3733.760.000.000.00
Days of Sales Outstanding18.440.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding1663.753733.760.000.000.00
Operating Cycle18.440.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.02-0.99-1.77-2.70-1.10
Free Cash Flow Per Share-1.02-0.99-1.94-2.90-1.11
Dividend Paid and CapEx Coverage Ratio-7055.78-243.34-10.51-13.96-65.42
Capital Expenditure Coverage Ratio-7055.78-243.34-10.51-13.96-65.42
Operating Cash Flow Coverage Ratio-3.40-2.86-3.31-4.72-214.10
Operating Cash Flow to Sales Ratio-4.58-3.570.000.000.00
Free Cash Flow Yield-88.87%-63.51%-107.81%-216.28%-10.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.90-1.18-0.97-0.37-4.65
Price-to-Sales (P/S) Ratio5.165.650.000.000.00
Price-to-Book (P/B) Ratio1.340.760.570.281.35
Price-to-Free Cash Flow (P/FCF) Ratio-1.13-1.57-0.93-0.46-9.86
Price-to-Operating Cash Flow Ratio-1.13-1.58-1.02-0.50-10.01
Price-to-Earnings Growth (PEG) Ratio0.300.040.02-0.01-0.01
Enterprise Value Multiple-1.01-1.40-1.040.95-1.14
Enterprise Value74.72M91.90M83.50M-116.11M78.92M
EV to EBITDA-1.01-1.40-1.040.95-1.14
EV to Sales5.395.690.000.000.00
EV to Free Cash Flow-1.18-1.59-1.081.21-2.20
EV to Operating Cash Flow-1.18-1.59-1.181.30-2.23
Tangible Book Value Per Share0.862.022.544.878.11
Shareholders’ Equity Per Share0.862.073.154.878.11
Tax and Other Ratios
Effective Tax Rate-0.020.030.000.000.00
Revenue Per Share0.220.280.000.000.00
Net Income Per Share-1.28-1.32-1.85-3.65-2.36
Tax Burden1.020.971.001.001.00
Interest Burden1.001.160.900.981.09
Research & Development to Revenue5.323.640.000.000.00
SG&A to Revenue1.601.570.000.000.00
Stock-Based Compensation to Revenue0.850.800.000.000.00
Income Quality0.800.750.960.740.46

Currency in USD